# Pharming Group (PHAR) — Analyst Forecast

PHAR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/phar/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 7 | 0 | 0 | 7 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 22, 2026 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Sep 14, 2026 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Aug 3, 2026 | Canaccord Genuity | Maintained | Buy | $38.00 |
| Apr 10, 2026 | Canaccord Genuity | Initiated Coverage | Buy | $37.00 |
| Mar 24, 2026 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Mar 13, 2026 | Oppenheimer | Maintained | Outperform | $41.00 |
| Mar 21, 2025 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Mar 20, 2025 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Mar 14, 2025 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Mar 14, 2025 | Oppenheimer | Maintained | Outperform | $39.00 |
| Dec 17, 2024 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Dec 16, 2024 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Dec 11, 2024 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Dec 9, 2024 | Jefferies | Initiated Coverage | Buy | $14.00 |
| Oct 28, 2024 | Oppenheimer | Maintained | Outperform | $30.00 |
| Oct 24, 2024 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Oct 15, 2024 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Oct 10, 2024 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Sep 26, 2024 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Aug 1, 2024 | HC Wainwright & Co. | Maintained | Buy | $37.00 |

## Frequently Asked Questions

### Is PHAR a buy, sell, or hold?

Analysts covering Pharming Group currently average a Buy rating: 7 buy, 0 hold and 0 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on PHAR?

On Sep 22, 2026, HC Wainwright & Co. maintained Pharming Group at Buy with a price target of $37.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).